Selection of TAR RNA-Binding Chameleon Peptides by Using a Retroviral Replication System

Journal of Virology

Volumn 78, Issue 3, 2004, Pages 1456-1463

  Xie, Baode ^a,b   Calabro, Valerie ^a   Wainberg, Mark A ^b   Franke, Alan D ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PEPTIDE DERIVATIVE; PROTEIN TAR; RNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BOVINE IMMUNODEFICIENCY LIKE VIRUS; COMBINATORIAL LIBRARY; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; JEMBRANA DISEASE VIRUS; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RETROVIRUS; RNA SEQUENCE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; CATTLE; CELL LINE; COMBINATORIAL CHEMISTRY TECHNIQUES; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LENTIVIRUS; MICE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PEPTIDE LIBRARY; PEPTIDES; RNA, VIRAL; RNA-BINDING PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 0347634400     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.3.1456-1463.2004     Document Type: Article

References (62)

1. Aboul-ela, F., J. Karn, and G. Varani. 1995. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol. 253:313-332.
2. Barboric, M., R. Taube, N. Nekrep, K. Fujinaga, and B. M. Peterlin. 2000. Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus. J. Virol. 74:6039-6044.
3. Berkhout, B., and K. T. Jeang. 1991. Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains. Nucleic Acids Res. 19:6169-6176.
4. Berkhout, B., and B. Klaver. 1993. In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res. 21:5020-5024.
5. Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:7056-7065.
6. Bogerd, H. P., H. L. Wiegand, P. D. Bieniasz, and B. R. Cullen. 2000. Functional differences between human and bovine immunodeficiency virus Tat transcription factors. J. Virol. 74:4666-4671.
7. Bres, V., R. Kiernan, S. Emiliani, and M. Benkirane. 2002. Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication. J. Biol. Chem. 277:22215-22221.
8. Bres, V., H. Tagami, J. M. Peloponese, E. Loret, K.-T. Jeang, Y. Nakatani, S. Emiliani, M. Benkirane, and R. E. Kiernan. 2002. Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J. 16:6811-6819.
9. Calnan, B. J., B. Tidor, S. Biancalana, D. Hudson, and A. D. Frankel. 1991. Arginine-mediated RNA recognition: the arginine fork. Science 252:1167-1171.
10. Chen, D., Y. Fong, and Q. Zhou. 1999. Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc. Natl. Acad. Sci. USA 96:2728-2733.
11. Chen, L., and A. D. Frankel. 1994. An RNA-binding peptide from bovine immunodeficiency virus Tat protein recognizes an unusual RNA structure. Biochemistry 33:2708-2715.
12. Chen, L., and A. D. Frankel. 1995. A peptide interaction in the major groove of RNA resembles protein interactions in the minor groove of DNA. Proc. Natl. Acad. Sci. USA 92:5077-5081.
13. Cujec, T. P., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin. 1997. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:2645-2657.
14. Dang, C. V., and W. M. Lee. 1989. Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J. Biol. Chem. 264:18019-18023.
15. Das, A. T., B. Klaver, and B. Berkhout. 1998. The 5′ and 3′ TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J. Virol. 72:9217-9223.
16. Dorr, A., V. Kiermer, A. Pedal, H. R. Rackwitz, P. Henklein, U. Schubert, M. M. Zhou, E. Verdin, and M. Ott. 2002. Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J. 21:2715-2723.
17. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4049.
18. Frankel, A. D. 2000. Fitting peptides into the RNA world. Curr. Opin. Struct. Biol. 10:332-340.
19. Fujinaga, K., T. P. Cujec, J. Peng, J. Garriga, D. H. Price, X. Grana, and B. M. Peterlin. 1998. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72:7154-7159.
20. Fujinaga, K., R. Taube, J. Wimmer, T. P. Cujec, and B. M. Peterlin. 1999. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96:1285-1290.
21. Garber, M. E., P. Wei, V. N. KewalRamani, P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:3512-3527.
22. Garcia-Martinez, L. F., G. Mavankal, J. M. Neveu, W. S. Lane, D. Ivanov, and R. B. Gaynor. 1997. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:2836-2850.
23. Gold, M. O., X. Yang, C. H. Herrmann, and A. P. Rice. 1998. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo. J. Virol. 72:4448-4453.
24. Hauber, J., M. H. Malim, and B. R. Cullen. 1989. Mutational analysis of the conserved basic domain of human immunodeficiency virus Tat protein. J. Virol. 63:1181-1187.
25. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
26. Huang, L. M., A. Joshi, R. Willey, J. Orenstein, and K. T. Jeang. 1994. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:2886-2896.
27. Ivanov, D., Y. T. Kwak, E. Nee, J. Guo, L. F. Garcia-Martinez, and R. B. Gaynor. 1999. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J. Mol. Biol. 288:41-56.
28. Kameoka, M., M. Morgan, M. Binette, R. S. Russell, L. Rong, X. Guo, A. Mouland, L. Kleiman, C. Liang, and M. A. Wainberg. 2002. The Tat protein of human immunodefiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription. J. Virol. 76:3637-3645.
29. Kameoka, M., L. Rong, M. Gotte, C. Liang, R. S. Russell, and M. A. Wainberg. 2001. Role for human immunodeficiency virus type I Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication. J. Virol. 75:2675-2683.
30. Kiernan, R. E., C. Vanhulle, L. Schiltz, E. Adam, H. Xiao, F. Maudoux, C. Calomme, A. Burny, Y. Nakatani, K.-T. Jeang, M. Benkirane, and C. Van Lint. 1999. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18:6106-6118.
31. Klaver, B., and B. Berkhout. 1994. Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J. 13:2650-2659.
32. Kwak, Y. T., D. Ivanov, J. Guo, E. Nee, and R. B. Gaynor. 1999. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. J. Mol. Biol. 288:57-69.
33. Long, K. S., and D. M. Crothers. 1995. Interaction of human immunodeficiency virus type I Tat-derived peptides with TAR RNA. Biochemistry 34:8885-8895.
34. Long, K. S., and D. M. Crothers. 1999. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA. Biochemistry 38:10059-10069.
35. Luo, Y., and B. M. Peterlin. 1993. Juxtaposition between activation and basic domains of human immunodeficiency virus type I Tat is required for optimal interactions between Tat and TAR. J. Virol. 67:3441-3445.
36. Mancebo, H. S., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:2633-2644.
37. Milligan, J. F., and O. C. Uhlenbeck. 1989. Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 180:51-62.
38. Narayana, N., and M. A. Weiss. 1999. RNA recognition by arginine-rich peptide motifs. Biopolymers 48:167-180.
39. Neuveut, C., and K.-T. Jeang. 1996. Recombinant human immunodeficiency virus type I genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J. Virol. 70:5572-5581.
40. Ott, M., M. Schnolzer, J. Garnica, W. Fischle, S. Emiliani, H. R. Rackwitz, and E. Verdin. 1999. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol. 9:1489-1492.
41. Puglisi, J. D., L. Chen, S. Blanchard, and A. D. Frankel. 1995, Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex. Science 270:1200-1203.
42. Puglisi, J. D., R. Tan, B. J. Calnan, A. D. Frankel, and J. R. Williamson. 1992. Conformation of the TAR RNA-arginine complex by NMR spectroscopy. Science 257:76-80.
43. Ramanathan, Y., S. M. Reza, T. M. Young, M. B. Mathews, and T. Pe'ery. 1999. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type I Tat and carboxy-terminal domain substrate. J. Virol. 73:5448-5458.
44. Reines, D., R. C. Conaway, and J. W. Conaway. 1999. Mechanism and regulation of transcriptional elongation by RNA polymerasc II. Curr. Opin. Cell Biol. 11:342-346.
45. Richter, S., Y. H. Ping, and T. M. Rana. 2002. TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication. Proc. Natl. Acad. Sci. USA 99:7928-7933.
46. Roof, P., R. M., P. Genin, M. A. Montano, M. Essex, M. A. Wainberg, A. Gatignol, and J. Hiscott. 2002. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-κB and the Tat transactivator. Virology 296:77-83.
47. Ruben, S., A. Perkins, R. Purcell, K. Joung, R. Sia, R. Burghoff, W. A. Haseltine, and C. A. Rosen. 1989. Structural and functional characterization of human immunodeficiency virus Tat protein. J. Virol. 63:1-8.
48. Siomi, H., H. Shida, M. Maki, and M. Hatanaka. 1990. Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J. Virol. 64:1803-1807.
49. Smith, C. A., V. Calabro, and A. D. Frankel. 2000. An RNA-binding chameleon. Mol. Cell 6:1067-1076.
50. Smith, C. A., S. Crotty, Y. Harada, and A. D. Frankel. 1998. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins. Biochemistry 37:10808-10814.
51. Tan, R., and A. D. Frankel. 1998. A novel glutamine-RNA interaction identified by screening libraries in mammalian cells. Proc. Natl. Acad. Sci. USA 95:4247-4252.
52. Tao, J., and A. D. Frankel. 1993. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins. Proc. Natl. Acad. Sci. USA 90:1571-1575.
53. Taube, R., K. Fujinaga, J. Wimmer, M. Barboric, and B. M. Peterlin. 1999. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology 264:245-253.
54. Ulich, C., A. Dunne, E. Parry, C. W. Hooker, R. B. Gaynor, and D. Harrich. 1999. Functional domains of Tat required for efficient human immundeficiency virus type 1 reverse transcription. J. Virol. 73:2499-2508.
55. Verhoef, K., and B. Berkhout. 1999. A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus. J. Virol. 73: 2781-2789.
56. Verhoef, K., M. Koper, and B. Berkhout. 1997. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type I replication. Virology 237:228-236.
57. Weeks, K. M., and D. M. Crothers. 1991. RNA recognition by Tat-derived peptides: interaction in the major groove? Cell 66:577-588.
58. Weeks, K. M., and D. M. Crothers. 1992. RNA binding assays for Tat-derived peptides: implications for specificity. Biochemistry 31:10281-10287.
59. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
60. Xie, B., M. A. Wainberg, and A. D. Frankel. 2003. Replication of human immunodeficiency viruses engineered with heterologous Tat- transactivation response element interactions. J. Virol. 77:1984-1991.
61. Ye, X., R. A. Kumar, and D. J. Patel. 1995. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex. Chem. Biol. 2:827-840.
62. Zhang, J., N. Tamilarasu, S. Hwang, M. E. Garber, I. Huq, K. A. Jones, and T. M. Rana. 2000. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. J. Biol. Chem. 275:34314-34319.